Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Panic selling
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(19)
•••
Comment by Smiles62on Jun 24, 2020 8:25am
64 Views
Post# 31184732

RE:RE:RE:RE:RE:RE:Panic selling

RE:RE:RE:RE:RE:RE:Panic selling
gainwidpatience wrote: This is only my guess:
Seems like sp was brought down so that Guy can acquire more voting shares. See Mar 11 (before NR on Covid trial), he intended ('plan') to convert the debt into equity @0.05. Sp is now stagnant at that price and he also converted at the same price after 3 months!
https://web.tmxmoney.com/article.php?newsid=7016403234918464&qm_symbol=LBL

Once the litigation is settled, Cheryl Farmer will receive 18m shares and warrants. Guy and Cheryl doesn't share good equation. It's good for Guy to have more shares!

i am predicting NR will be out in July (seems to me realistic to guess)! Patience is key here. Sp can go up very quickly if they give positive status/results.
Maybe our friend here is Cheryl Farmer.  Don't forget if she thinks this thing is worth it she would also get into the fight of owning a bigger chunk of the company.  So basically there are 3 major holders of this company.  Anyone here Cheryl, how can I get in contact with her?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities